Regulatory Briefs: Open Data Website Launch; Upcoming FDA Meetings
This article was originally published in The Gray Sheet
Executive Summary
FDA launches openFDA website to provide access to datasets. Agency announces upcoming Ophthalmic Devices and Risk Communications meetings. More regulatory briefs.
You may also be interested in...
FDA Questions Missing Data, Sizing Method For Visian Astigmatism-Correcting Intraocular Lens
FDA is asking its Ophthalmic Devices Panel to consider the implications of missing data and issues with sizing methodology issues tied to Staar Surgical’s PMA submission for its Visian toric implantable collamer lens to correct myopic astigmatism in adults ages 21 to 45. The panel was scheduled for Feb. 14, but it has been postponed due to weather.
IPO Year In Review: Record-Year Bodes Well For 2021, And For More SPACs
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott Capitalizes On Pandemic Testing Boom; Device Sales Stay Almost Flat
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: